Literature DB >> 2766887

Measurement of S-phase fractions in lymphoid tissue comparing fresh versus paraffin-embedded tissue and 4',6'-diamidino-2 phenylindole dihydrochloride versus propidium iodide staining.

R S Camplejohn1, J C Macartney, R W Morris.   

Abstract

S-phase fractions for 62 lymphoid biopsies were calculated, by means of flow cytometry, from both fresh and paraffin-embedded tissue. The purposes of this study were to determine whether significant differences were seen between S-phase estimates obtained from fresh and fixed tissue and to compare results obtained with two DNA dyes, namely 4'-6'-diamidino-2 phenylindole dihydrochloride (DAPI) and propidium iodide (PI). The 62 cases consisted of 38 cases of non-Hodgkin's lymphoma (NHL), 19 reactive samples, and 5 cases of Hodgkin's disease. Fifty-four of the samples showed DNA diploid profiles. A good agreement between S-phase results from fresh and fixed tissue was seen, with technical factors accounting for around 20% of the total variance. Using a paired t test, no significant difference was seen between fresh and fixed tissue for diploid cases, but there was a trend for S-phase estimates from fixed tissue to be higher. If all cases (including the eight DNA aneuploid samples) were included in the analysis this difference just reached statistical significance (P less than .05). In a subgroup of 19 of the cases, a comparison was performed on both fresh and fixed tissue of staining with DAPI and PI. A good agreement between results with both DNA stains was found on fresh and fixed tissue, with no significant differences being apparent, and stain-related factors accounted for only 10% of the total variance.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2766887     DOI: 10.1002/cyto.990100408

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  24 in total

1.  DNA flow cytometry of follicular non-Hodgkin's lymphoma.

Authors:  J C Macartney; R S Camplejohn; R Morris; K Hollowood; D Clarke; A Timothy
Journal:  J Clin Pathol       Date:  1991-03       Impact factor: 3.411

Review 2.  Review: assessment of cell proliferation in histological material.

Authors:  P A Hall; D A Levison
Journal:  J Clin Pathol       Date:  1990-03       Impact factor: 3.411

3.  Expression of MIB-1, mitotic index and S-phase fraction as indicators of cell proliferation in superficial bladder cancer. Finnbladder Group.

Authors:  T J Liukkonen; P K Lipponen; M Helle; H K Haapasalo; S Nordling; P Rajala
Journal:  Urol Res       Date:  1996

4.  Diagnostic value of DNA image cytometry in ulcerative colitis.

Authors:  R Keller; E C Foerster; A Köhler; B Floer; G Winde; H J Terpe; W Domschke
Journal:  Dig Dis Sci       Date:  2001-04       Impact factor: 3.199

5.  Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma.

Authors:  S Jalkanen; H Joensuu; K O Söderström; P Klemi
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

6.  Aggressiveness of breast cancers found with and without screening.

Authors:  P J Klemi; H Joensuu; S Toikkanen; J Tuominen; O Räsänen; J Tyrkkö; I Parvinen
Journal:  BMJ       Date:  1992-02-22

7.  Proliferating cell nuclear antigen and S phase fraction in endometrial stromal sarcoma.

Authors:  J B Schofield; J Mansi; R S Camplejohn; D P Lane; C Fisher
Journal:  J Clin Pathol       Date:  1992-08       Impact factor: 3.411

8.  Markers of prognosis in breast cancer--the relationship between binding of the lectin HPA and histological grade, SPF, and ploidy.

Authors:  S A Brooks; A J Leathem; R S Camplejohn; W Gregory
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

9.  Glycoprotein CD44 expression and its association with survival in breast cancer.

Authors:  H Joensuu; P J Klemi; S Toikkanen; S Jalkanen
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

10.  Lymphocyte homing receptor (CD44) expression is associated with poor prognosis in gastrointestinal lymphoma.

Authors:  H Joensuu; R Ristamäki; P J Klemi; S Jalkanen
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.